Jim Cramer says this is the 'magic elixir' driving Tuesday's stock market

The Nasdaq moved into positive territory Tuesday as the 10-year Treasury yield fell, with Jim Cramer saying lower borrowing costs supported rate-sensitive stocks even as oil prices rose. Johnson & Johnson gained more than 2% and Eli Lilly rose over 4.5%, topping $1,300 per share for the first time. Apple slipped less than 1% after Loop Capital downgraded it to hold from buy, citing valuation and concerns about iPhone shipment projections.

Analysis

The key distinction is why yields are falling. If lower yields reflect easing inflation and stable growth, rate-sensitive equities can re-rate; if they reflect a flight to safety, weaker demand and wider credit spreads can overwhelm the discount-rate benefit. Higher oil makes the first interpretation less secure by keeping inflation expectations and the path of policy rates vulnerable. For AI infrastructure names such as CoreWeave and IREN, treat any relief rally as funding-duration beta, not evidence of improved unit economics; confirmation requires financing terms, cash generation and customer demand.

For Apple, a single channel-check downgrade is weak evidence on its own, but the consequential risk is estimate persistence: fall-through in shipments becomes a valuation problem only if forward revenue expectations are revised down or supply-chain data corroborate it. Watch subsequent estimate revisions and reported sell-through over the next 1–3 months; the 6–18 month question is whether replacement demand and product mix offset any shipment softness. For healthcare, a sharp move in Eli Lilly can increase the cost of disappointment, while Johnson & Johnson’s rebound does not itself establish that earnings risk has cleared. Neither one-day price action is a reliable fundamental signal.

Contrarian read: the market may be treating lower yields as uniformly bullish while ignoring the growth signal embedded in a safety bid. The memo’s signal is mixed; avoid broad directional extrapolation from this session.

Key Decisions for Investors

• Do not chase CRWV or IREN solely on a yield-driven bounce. Consider incremental exposure only if yields fall without credit spreads widening and company disclosures support improving funding and cash-flow economics; reduce the thesis if spreads widen or financing access deteriorates.
• For AAPL, maintain a monitor rather than trade the downgrade headline: require corroboration from estimate revisions or additional shipment/sell-through evidence before changing exposure. A sustained cut to forward revenue estimates would falsify the long-term-noise interpretation and warrant reassessment.
• Keep healthcare exposure selective. Avoid adding to LLY on momentum alone; for JNJ, look for subsequent earnings or guidance evidence before treating the recovery as confirmation. No compelling relative-value pair is established by this article.
• Over the next several weeks, track Treasury yields alongside oil, inflation expectations and credit spreads. If yields fall while spreads widen or growth indicators weaken, favor lower balance-sheet sensitivity over financing-dependent rate-beta names; if yields ease with stable spreads, that downside signal is less persuasive.